News on Medial

HooLiv raises Rs 24 Cr in pre-Series A round led by Negen Capital

EntrackrEntrackr · 2d ago
HooLiv raises Rs 24 Cr in pre-Series A round led by Negen Capital
Medial

HooLiv raises Rs 24 Cr in pre-Series A round led by Negen Capital Student co-living platform HooLiv has raised Rs 24 crore ($2.73 million) in a pre-Series A funding round led by Negen Capital, along with participation from other institutional investors, family offices, and angel investors. The proceeds will be used to expand HooLiv’s operations in non-metro cities through new bed acquisitions, brand-building, and enhancements to its property management platform. The company also plans to replicate its business model internationally. Founded by Chinmoy Mishra, Rasmi Mishra, Gaurav Vij, and Abhishek Verma, HooLiv operates purpose-built student accommodations that cater to students in universities and coaching hubs. The platform focuses on providing organized, technology-enabled student housing that ensures standardized operations, consistent living conditions, and cost efficiency for both property owners and students. HooLiv’s model combines real estate management and technology to offer integrated housing solutions, including maintenance, security, and community engagement features. The company works with property owners and educational institutions to convert and manage large-scale facilities as student housing assets. HooLiv plans to bridge the demand-supply gap in India’s organized student housing segment, driven by the growing number of universities and coaching centers across the country.

Related News

Good Flippin’ Burgers raises capital from Tanglin Venture

EntrackrEntrackr · 1y ago
Good Flippin’ Burgers raises capital from Tanglin Venture
Medial

Quick service burger chain Good Flippin’ Burgers has raised Rs 30 crore (approximately $3.6 million) in an extended Series A round from its existing investor Tanglin Venture Partners. The board at Good Flippin’ Burgers has passed a special resolution to issue 34,366 Series A1 cumulative compulsory convertible preference shares at an issue price of Rs 8739.56 each to raise Rs 30 crore, its regulatory filing accessed from the RoC shows. With this, the company has secured $8.6 million to date including a $4 million Series A round led by Tanglin Venture Partners in June 2023. According to TheKredible estimate, the company has been valued at around Rs 400 crore or $48 million (post-money). This marked a 3X growth in the valuation when compared to its last funding. Founded by Viren D’silva, Sijo Mathew, and Sid Marchant, Good Flippin’ Burgers currently has 25 outlets across Mumbai, Delhi, Gurgaon, and Noida. The outlets offer delivery services directly through their website and online aggregators such as Zomato and Swiggy. Five-year-old Good Flippin’ Burgers reported strong growth in its scale during FY23 as its operating revenue spiked 3.58X to Rs 32.53. When it comes to the bottom line, the company posted Rs 3.91 crore loss in the fiscal year ending March 2023. It’s yet to disclose its FY24 numbers. The Mumbai-based startup competes with Burger Singh, Whataburger, and Biggies Burger. In September 2022, Biggies Burger secured Rs 5.5 crore in seed round led by Indian Angel Network. Burger Singh also bagged Rs 30 crore in a Series A round led by Negen Capital in July 2022.

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group

EntrackrEntrackr · 3m ago
Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group
Medial

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group Lamark's proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. Biopharma startup Lamark Biotech has raised Rs 6.5 crore in a pre-Series A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Vinayender Tulla, Nita Roy, and Venkataraman KNK. Domain experts from IAN’s angel investors led the round. The Ahmedabad-based company had previously raised $41.3K in a seed funding round led by VIT-TBI and others. The fresh funds will be utilized to accelerate the development of thermostable insulin and expand the biologics platform for global access, Lamark said in a press release. Founded in 2018 by Vaibhav Bhatia, Lamark Biotech aims to reimagine drug delivery for chronic and life-altering diseases. Its proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. According to Lamark Biotech, it leverages the R&D base of Venture Center, NCL Innovation, and it is advancing a new class of temperature-resilient biologics that retain potency across extreme conditions—ideal for underserved regions where cold storage infrastructure is limited. With its lead program, InsulinStrong, Lamark is targeting the Rs 4,000 crore Indian insulin market and intends to expand across Southeast Asia and the UAE. In the next 24 months, it plans to file new international patents, begin early clinical trials, and build partnerships with pharma companies, CDMOs, and global health agencies.

Download the medial app to read full posts, comements and news.